Intraarticular injection of relaxin-2 alleviates shoulder arthrofibrosis
نویسندگان
چکیده
منابع مشابه
Intraarticular arthrofibrosis of the knee alters patellofemoral contact biomechanics
BACKGROUND Arthrofibrosis in the suprapatellar pouch and anterior interval can develop after knee injury or surgery, resulting in anterior knee pain. These adhesions have not been biomechanically characterized. METHODS The biomechanical effects of adhesions in the suprapatellar pouch and anterior interval during simulated quadriceps muscle contraction from 0 to 90° of knee flexion were assess...
متن کاملIntraarticular injection of infliximab.
3. Information on permissions/orders of reprints in rheumatology and related fields. Silverman featuring research articles on clinical subjects from scientists working is a monthly international serial edited by Earl D.
متن کاملSteroid Flare Reaction; a Complication of Intraarticular Steroid Injection
A 63 year old man with bilateral knee osteoarthritis underwent an intraarticular steroid injection. After two days the patient developed severe pain and marked effusion in the left knee joint. Cultures were negative. He subsequently underwent bilateral knee replacement. The synovial biopsy of the left knee revealed marked granulation tissue and peculiar neutrophilic response against degenerated...
متن کاملIntraarticular injection and closed glenohumeral reduction with emergency ultrasound.
A 52-year-old man with no significant medical history presented to the emergency department (ED) after a mechanical fall onto his nondominant left hand. Physical examination was suggestive of a glenohumeral dislocation, and radiographs confirmed a subcoracoid anterior glenohumeral dislocation (Figure 1). The patient was neurovascularly intact, but complained of severe pain and refused initial a...
متن کاملAcute Intravenous Injection of Serelaxin (Recombinant Human Relaxin‐2) Causes Rapid and Sustained Bradykinin‐Mediated Vasorelaxation
BACKGROUND A recent clinical trial (RELAXin in Acute Heart Failure [RELAX-AHF]) demonstrated that 48 hours of continuous intravenous infusion of the vasorelaxant peptide serelaxin (recombinant human relaxin-2) to patients with acute heart failure reduced cardiovascular mortality at 180 days. The persistence of a vasorelaxant response as a potential mechanism for this long-term benefit and the v...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Proceedings of the National Academy of Sciences
سال: 2019
ISSN: 0027-8424,1091-6490
DOI: 10.1073/pnas.1900355116